JRCT ID: jRCT2080223895
Registered date:08/05/2018
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 01/05/2018 |
Target sample size | 174 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : turoctocog alfa pegol Therapeutic category code : 634 Human blood preparations Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | safety |
---|---|
Secondary Outcome | safety efficacy |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Male |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT03528551,JapicCTI-183952 |
Contact
Public contact | |
Name | |
Address | |
Telephone | |
JPHC_clinical_trials@novonordisk.com | |
Affiliation | |
Scientific contact | |
Name | |
Address | |
Telephone | |
JPHC_clinical_trials@novonordisk.com | |
Affiliation |